Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

RSS icon

Updated COVID-19 booster protects against subvariants, new study confirms

The findings stem from a new CDC study comparing people who received the new booster and those who received between two to four doses of the original vaccine.

Thumbnail

Cardiologists use video-based AI model to ID coronary artery disease

A team of specialists out of Cedars-Sinai developed the deep learning model using TTEs from nearly 3,000 patients.

Amazon launches $5 prescription services program

The medications included in the program treat more than 80 conditions.

Thumbnail

AI in cardiology: A step-by-step guide to developing high-quality algorithms

Overwhelmed or confused by AI and machine learning technology? A new analysis in European Heart Journal hopes to provide some clarity. 

FDA proposes major shift to COVID vaccine schedule

Under the new proposal, the FDA would conduct an assessment of prevalent strains circulating each year, likely beginning around June, with the aim of new vaccines being ready by September. 

More Americans are putting off care than ever before

The percentage of Americans who are postponing medical care has reached a new high, according to a recent Gallup poll.

insurance payer payment insurer

Uninsured rate dropped during COVID-19 pandemic

The uninsured rate in the United States saw a drop from 11.1% in 2019 to 10.5% in 2021, according to a new report from the Department of Health and Human Services (HHS).

Pfizer expands not-for-profit products initiative

Pharmaceutical giant Pfizer is expanding its not-for-profit products, widening its existing initiative with the aim of lowering health inequities.

Displaying 377 - 384 of 573

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup